Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 10, No 4 (2014) STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN Abstract  similar documents
N. G. Gogolashvili
"... and other cardiovascular events in patients with percutaneous coronary intervention is discussed. ..."
 
Vol 6, No 4 (2010) RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
M. V. Ezhov
"... coronary syndrome, chronic coronary heart disease, and percutaneous coronary interventions. Studies ..."
 
Vol 13, No 4 (2017) HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? Abstract  similar documents
I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova
"... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..."
 
Vol 13, No 3 (2017) ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING Abstract  similar documents
A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya
"... revascularization of the myocardium. Immediately before the intervention, the dose of atorvastatin was increased ..."
 
Vol 4, No 3 (2008) ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS Abstract  similar documents
V. A. Sulimov
"... Possibilities of modern antiplatelet and antithrombotic therapy at percutaneous coronary ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
"... , Seidinger D, et al. Atorvastatin reduces thrombin generation after percutaneous coronary intervention ..."
 
Vol 9, No 6 (2013) ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? Abstract  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein
"... heart disease after percutaneous coronary intervention and its contribution to antiplatelet therapy ..."
 
Vol 15, No 2 (2019) The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention Abstract  similar documents
A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov
"... syndrome who have undergone percutaneous coronary intervention. Considering the pronounced antiplatelet ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... is - the lower risk of cardiovascular diseases and their complications are. Efficacy and safety of atorvastatin ..."
 
Vol 7, No 2 (2011) LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE Abstract  similar documents
A. V. Susekov, N. V. Khokhlova
"... of atorvastatin is demonstrated in according to comparative studies. Results of clinical studies on atorvastatin ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... to daily maintenance) on long-term prognosis after elective percutaneous coronary intervention (PCI ..."
 
Vol 11, No 2 (2015) CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva
"... is described. Percutaneous coronary intervention was successful after the balanced medication with 2 ..."
 
Vol 7, No 6 (2011) CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM Abstract  similar documents
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov
"... and thrombus in the LV aneurysm is considered in details. Successful percutaneous coronary intervention (PCI ..."
 
Vol 15, No 1 (2019) Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction Abstract  PDF (Eng)  similar documents
Mohamed Hassan Nab, Shaimaa Mostafa, Khaled Elrabat, Hamza Kabil, Neama Elmelegy
"... of I/C vs I/V bolus regimen dose of eptifibatide during primary percutaneous coronary intervention ..."
 
Vol 15, No 2 (2019) Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction Abstract  similar documents
A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh
 
Vol 6, No 6 (2010) COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE Abstract  similar documents
S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova
"... to therapy with atorvastatin and rosuvastatin was demonstrated in recent studies. The advantage of aggressive ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
"... мета-анализов. Ключевые слова: сердечно-сосудистые осложнения, инсульт, статины, аторвастатин ..."
 
Vol 8, No 3 (2012) CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
N. P. Lyamina, A. N. Nosenko, I. B. Razborova, O. V. Orlikova, E. V. Kotel'nikova, E. S. Karpova
"... ) with left ventricle diastolic dysfunction (DD) who underwent percutaneous coronary intervention (PCI ..."
 
Vol 9, No 6 (2013) THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) Abstract  similar documents
V. A. Sulimov
"... , coupled with timely coronary angiography, and primary percutaneous coronary intervention (PCI ..."
 
Vol 6, No 3 (2010) QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY Abstract  similar documents
A. V. Susekov, V. A. Bulatov, A. V. Vigdorchik
"... , перенесшие успешную чрескожную транслюминальную ангиопластику, которым был назначен флувастатин замедленного ..."
 
Vol 12, No 5 (2016) Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention Abstract  similar documents
E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva
"... pharmacological strategies, complications and adverse events following percutaneous coronary interventions (PCI ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... чрескожное коронарное вмешательство (ЧКВ). Материал и методы. Через месяц после ЧКВ (Т-0) 50 больных были ..."
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... in percutaneous coronary intervention (PCI), to identify clinical risk factors of resistance development, to study ..."
 
Vol 11, No 1 (2015) CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, S. V. Utkina
"... an amino acid sequence of staphylokinase was successful, hereafter percutaneous coronary interventions were ..."
 
Vol 11, No 3 (2015) CLINICAL ASPECTS OF PATIENT SELECTION FOR CORONARY ANGIOGRAPHY IN NON-ST ELEVATION ACUTE CORONARY SYNDROME Abstract  similar documents
K. A. Kireev
"... , percutaneous coronary intervention, non-ST elevation acute coronary syndrome, GRACE risk scale. Ration ..."
 
Vol 11, No 6 (2015) Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem Abstract  similar documents
S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuz'mina
"... stage after acute myocardial infarction onset compared with primary percutaneous coronary intervention ..."
 
Vol 7, No 2 (2011) COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE Abstract  similar documents
V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko
"... on reperfusion strategy (no reperfusion, percutaneous coronary intervention (PCI), prehospital thrombolysis ..."
 
Vol 14, No 3 (2018) NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES Abstract  similar documents
G. S. Galjautdinov1, I. V. Gorelkin, K. R. Ibragimova, R. R. Sadriev
"... the myocardial ischemia and AF appearance. Inefficient reperfusion during percutaneous coronary intervention ..."
 
Vol 14, No 6 (2018) P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva
"... coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) are discussed in the article ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... antihypertensive and glucose-lowering therapy. Patients of group 1 were additionally receiving atorvastatin 20 mg ..."
 
Vol 4, No 1 (2008) OPTIMIZATION OF THE TREATMENT OF ELDERLY PATIENTS WITH MYOCARDIAL INFARCTION BY REVASCULARIZATION IN COMBINATION WITH INOTROPIC STIMULATION AND MYOCARDIAL UNLOADING Abstract  similar documents
D. S. Krivonosov, L. Yu. Chesnokova, N. I. Tarasov
"... to the additional therapeutic maneuvers patients were split into four groups: 18 patients treated with percutaneous ..."
 
Vol 9, No 3 (2013) IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION Abstract  similar documents
P. A. Shesternya, G. V. Matyushin, S. Yu. Nikulina, A. S. Sergeeva
"... ) and coronary atherosclerosis severity and long-term outcomes after percutaneous coronary intervention (PCI ..."
 
Vol 14, No 4 (2018) Antithrombotic Therapy after Bleeding in Elderly Polimorbid Patient: Our Time Challenge Abstract  similar documents
M. R. Atabegashvili, M. Yu. Gilyarov, E. V. Konstantinova, A. N. Kostina, A. P. Nesterov, T. D. Pakharkova, A. E. Udovichenko
"... . An emergency percutaneous coronary intervention was performed, the infarct-dependent artery was stented ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... . The study included 81 patients with acute coronary syndrome (ACS) and subsequent percutaneous coronary ..."
 
Vol 15, No 4 (2019) According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention Abstract  similar documents
Company Pfizer
"... неклапанной фибрилляции предсердий и острым коронарным синдромом и/или чрескожным коронарным вмешательством ..."
 
Vol 6, No 4 (2010) QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY Abstract  similar documents
A. V. Susekov, V. A. Bulatov, A. V. Vigdorchik
"... . Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a ..."
 
Vol 13, No 6 (2017) HEART RATE VARIABILITY, VENTRICULAR LATE POTENTIALS AND HEART RATE TURBULENCE AS INDICATORS OF CORONARY REPERFUSION IN ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
E. A. Shigotarova, E. V. Dushina, V. A. Galimskaya, V. E. Oleynikov
"... criteria, followed by (3-24 hour later) coronary angiography with percutaneous coronary intervention (PCI ..."
 
Vol 14, No 2 (2018) WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
M. Yu. Gilyarov, Е. V. Konstantinova
"... be considered in patients with ACS with percutaneous coronary intervention (PCI). Prasugrel therapy ..."
 
Vol 14, No 3 (2018) ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
D. B. Nemik, G. V. Matyushin, S. A. Ustyugov
"... of percutaneous coronary intervention one of these factors is the severity of the coronary bed lesion. In clinical ..."
 
Vol 6, No 5 (2010) THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets
"... Aim. To study the effect of atorvastatin on the rate of atrial fibrillation (AF) recurrence after ..."
 
Vol 4, No 2 (2008) EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY Abstract  similar documents
A. V. Semenov, D. A. Sichev, V. G. Kukes
"... Aim. To study effects of genes SLCO1B1 and MDR1 polymorphism on atorvastatin pharmacokinetics ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... -term safety and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ..."
 
Vol 12, No 3 (2016) EFFECT OF GENDER DIFFERENCES ON THE EFFICACY AND SAFETY OF REPERFUSION THERAPY OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (DATA OF RETROSPECTIVE SINGLE-CENTER STUDY – HOSPITAL PERIOD) Abstract  PDF (Eng)  similar documents
D. B. Nemik, G. V. Matyushin, A. V. Protopopov, A. V. Shulmin, S. A. Ustyugov
"... in single-center retrospective study. Primary percutaneous coronary intervention (pPCI) and pharmacoinvasive ..."
 
Vol 4, No 3 (2008) DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY Abstract  similar documents
E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin
"... ) and paroxysmal atrial fibrillation (AF) during atorvastatin therapy. Material and methods. 60 patients with IHD ..."
 
Vol 11, No 6 (2015) RESULTS OF TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DATA OF A RETROSPECTIVE, SINGLE-CENTER STUDY (IN-HOSPITAL PERIOD) Abstract  similar documents
D. B. Nemick, G. V. Matyushin, A. V. Protopopov, S. A. Ustyugov, A. V. Shulmin
"... treatment: primary percutaneous coronary intervention (PPCI) or pharmacoinvasive strategy (PIS) methods. All ..."
 
Vol 11, No 1 (2015) ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE Abstract  similar documents
M. V. Solodun, S. S. Yakushin
"... on the efficacy of atorvastatin therapy and the incidence of the combined endpoint in patients after myocardial ..."
 
Vol 11, No 5 (2015) Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease Abstract  similar documents
O. A. Rubanenko
"... Aim. To evaluate the efficacy of atorvastatin therapy in prevention of atrial fibrillation (AF ..."
 
Vol 1, No 3 (2005) PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE Abstract  similar documents
V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova
"... with initial dislipidemia were prescribed lipid reducing drug atorvastatin in 10mg daily dose additionally ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... of therapy with atorvastatin in different doses in patients with acute ST-segment elevation myocardial ..."
 
Vol 2, No 2 (2006) METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS Abstract  similar documents
N. V. Perova, I. N. Ozerova, V. A. Metelskaya
"... , скавенджер-рецептор, аторвастатин. РФК 2006; 2: 49-56 Metabolic system of cholesterol elimination from ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... .5%, whereas prescription of atorvastatin and rosuvastatin increased from 31.4% to 64.5% and from 3.6% to 9 ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... visit (V0), and visits after 1 and 3 months of follow-up (V1 and V3). The use of generic atorvastatin ..."
 
Vol 1, No 3 (2005) EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim
"... дженериков аторвастатина - препарата Тулип в сравнении с дженериком симвастатина Вазилипом у пациентов с ..."
 
Vol 11, No 1 (2015) EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Andreev, D. A. Sychev
"... of the research on the change of antiplatelet therapy in patients with ischemic heart disease after percutaneous ..."
 
Vol 3, No 1 (2007) MICROCIRCULATORY ISCHEMIA AND STATINS: LESSONS OF INTERVENTION CARDIOLOGY Abstract  similar documents
An. A. Alexandrov, I. I. Tchukaeva
"... percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol ..."
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
"... hypertension, dyslipidemia, treatment, perindopril, indapamide, atorvastatin. Rational Pharmacotherapy in ..."
 
Vol 6, No 6 (2010) TENEKTEPLASE: NEW POSSIBILITIES FOR SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
N. A. Novikova, A. E. Udovichenko
"... plasminogen activator are presented. Efficacy of thrombolytic therapy and percutaneous coronary interventions ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... acute coronary syndrome and/or percutaneous coronary interventions are considered. Features ..."
 
Vol 8, No 6 (2012) ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE Abstract  similar documents
A. I. Chesnikova, V. A. Safronenko, A. V. Hripun
"... , despite the high rate of percutaneous coronary intervention (77.4%) and hypolipidemic therapy ..."
 
Vol 13, No 1 (2017) EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 Abstract  similar documents
L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin
"... hospitalization in a Khabarovsk  hospital, which has an opportunity of primary percutaneous coronary  intervention ..."
 
Vol 5, No 3 (2009) REPERFUSION THERAPY IN ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION Abstract  similar documents
A. L. Alyavi, B. A. Alyavi
"... Aim. To compare effect of percutaneous balloon angioplasty (PCA) and a systemic thrombolysis (STL ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... with atorvastatin 80 mg/day. The results were considered statistically significant at p<0.05. Results. 16 (27 ..."
 
Vol 14, No 1 (2018) UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME Abstract  similar documents
O. V. Krikunova, R. I. Stryuk
"... in primary percutaneous coronary intervention and in the absence of revascularization). Of the entire range ..."
 
Vol 12, No 5 (2016) Statins in Secondary Prevention of Atrial Fibrillation Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... Aim. To study the effect of atorvastatin on the progression of the arrhythmia in hypertensive ..."
 
Vol 14, No 3 (2018) THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova
"... and schemes of its use in patients undergoing percutaneous coronary intervention, coronary artery bypass ..."
 
Vol 14, No 5 (2018) Effect of Previous Cardiovascular Diseases on Long-Term Outcomes of Acute Myocardial Infarction: Data of the Outpatient Registry "PROFILE-IM” Abstract  similar documents
N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, V. A. Evdakov, E. A. Kasparova, S. Yu. Martsevich
"... .28-15.4, p<0.001), percutaneous coronary intervention (RR 9.84; 95%CI 2.02-48.06, p<0.005), disability ..."
 
Vol 10, No 5 (2014) DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE Abstract  similar documents
G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov
"... of them underwent percutaneous coronary intervention with bare metal stent implantation. The information ..."
 
Vol 12, No 1 (2016) Characteristic features, treatment and hospital outcomes in patients with acute myocardial infarction: Khabarovsk Register data. Part I Abstract  similar documents
L. N. Malay, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, H. B. Garayev, A. Ya. Letskin
"... ) admitted to the hospital with a possibility of primary percutaneous coronary intervention (PCI), according ..."
 
Vol 15, No 2 (2019) Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL) Abstract  similar documents
I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov, V. A. Kokorin
"... percutaneous coronary intervention (PCI). Material and methods. The study was conducted with the inclusion ..."
 
Vol 9, No 3 (2013) ALGORITHM FOR MANAGEMENT OF HYPERTENSIVE PATIENTS UNDERWENT UROLOGY INTERVENTIONS Abstract  similar documents
S. S. Davydova
 
Vol 14, No 4 (2018) Some Aspects of Prehospital Thrombolytic Therapy in the Perm Region Abstract  similar documents
S. A. Naumov, N. S. Karpunina
"... therapy and percutaneous coronary intervention was also found. Recombinant staphylokinase was comparable ..."
 
Vol 15, No 4 (2019) Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova
"... syndrome and individuals undergoing percutaneous coronary intervention. This DOAC has strict indications ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
"... percutaneous coronary intervention reduces myonecrosis and improves clinical outcome. Catheter Cardiovasc ..."
 
Vol 11, No 1 (2015) ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS Abstract  similar documents
R. Bhattarai, S. A. Sayganov, E. V. Trofimova
"... with inferior MI, the second one – 23 patients with anterior MI. All patients underwent percutaneous ..."
 
Vol 13, No 2 (2017) TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1 Abstract  similar documents
M. Yu. Gilyarov, M. O. Zheltoukhova, E. V. Konstantinova, M. D. Muksinova, L. S. Muradova, A. P. Nesterov, A. E. Udovichenko
"... . The incidence of percutaneous coronary intervention (PCI) and coronary angiography (CAG) significantly increased ..."
 
Vol 13, No 1 (2017) CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION Abstract  similar documents
V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova
"... criteria) thrombolytic therapy (TLT) and the subsequent (after 3-24 hours) percutaneous coronary ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
"... coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI). Material and methods ..."
 
Vol 5, No 1 (2009) SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova
"... . Atorvastatin (Tulip, LEK) 20-40 mg OD was prescribed for HH control. Management of CG patients was performed ..."
 
Vol 15, No 3 (2019) The First Results of the Evaluation of Long-Term Nicorandil Treatment Effect on the Probability of Cardiovascular Complications in Patients with Stable Coronary Artery Disease (Data of Observational NIKEA Study) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
"... percutaneous coronary intervention was performed in 3 patients (in 2 patients due to acute MI, in 1 patient due ..."
 
Vol 11, No 5 (2015) Perioperative assessment of troponin level in the non-cardiac interventions: is there such a need? Abstract  similar documents
A. N. Sumin
 
Vol 15, No 3 (2019) Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation Abstract  similar documents
L. N. Uddin, A. V. Egorov, A. A. Sokolova, N. S. Morozova, D. A. Napalkov, V. V. Fomin
"... and hemorrhagic complications in patients with atrial fibrillation (AF) during planned surgical interventions ..."
 
Vol 13, No 3 (2017) ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION Abstract  similar documents
F. I. Belyalov
"... Contrast Induced Nephropa- thy and Outcomes After Primary Percutaneous Coronary Intervention in Patients ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... up to 8.3%. When choosing among statins specialists recommended significantly more often atorvastatin ..."
 
Vol 7, No 6 (2011) DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER Abstract  similar documents
I. S. Yavelov
"... to do intervention more effective and safer. ..."
 
Vol 13, No 5 (2017) ACUTE CORONARY SYNDROME DUE TO CORONARY VASOSPASM – CASE REPORT Abstract  similar documents
S. D. Klimovskiy, G. G. Gazaryan, M. D. Krichman, P. B. Pisetskiy, A. G. Koledinskiy, T. Sh. Mirilashvili
"... and absence of benefit from percutaneous coronary  interventions in most cases. A clinical case of the patient ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... .32% of patients, enalapril 20 mg/day – 30.45%, simvastatin and atorvastatin 20 mg/day – 64.52% and 47 ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
"... treatment with atorvastatin for the primary prevention of cardiovascular complications in patients ..."
 
Vol 12, No 3 (2016) EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY Abstract  PDF (Eng)  similar documents
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz
"... аторвастатин) с другими препаратами, в ме- таболизме которых принимает участие цитохром P450 (фибраты ..."
 
Vol 3, No 3 (2007) RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
"... percutaneous coronary intervention. Circulation 2005;111:2560-4. 20. Gorchakova O, von Beckerath N, Gawaz MЮ ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... with simvastatin, in 75.2% of the patients treated with atorvastatin, in 59% of the patients treated ..."
 
Vol 10, No 6 (2014) DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) Abstract  similar documents
A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov
"... atorvastatin 40 mg per day. Blood LDC levels were examined only in 5% of patients during statins therapy ..."
 
Vol 7, No 4 (2011) THE STICH TRIAL — THE IMPORTANCE OF DRUGS IN PATIENTS WITH CORONARY ARTERY DISEASE WAS HIGHER THAN EXPECTED Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
"... . This study goal was to evaluate the role of the surgical intervention for coronary artery bypass grafting ..."
 
Vol 13, No 6 (2017) SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS Abstract  similar documents
I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova
"... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... of coronary surgical interventions in our patients is significantly lower than in the other countries. Second ..."
 
Vol 14, No 2 (2018) HYPERTENSION AND DIABETES MELLITUS TYPE 2 Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... , hypolipidemic therapy with atorvastatin 17.0Ѓ}4.7 mg/day and combined hypoglycemic therapy with metformin 1093 ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... . This causes difficulties in choosing tactic of prophylactic intervention, especially for intermediate risk ..."
 
Vol 1, No 2 (2005) STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY Abstract  similar documents
Y. A. Karpov
"... , в которых оценивалось влияние аторвастатина (Липримар) на риск развития ИБС и его основных ..."
 
Vol 12, No 6 (2016) THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME Abstract  similar documents
E. A. Smirnova, S. S. Yakushin
"... was the main parenteral anticoagulant therapy for ACS for several decades, including percutaneous coronary ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... underwent percutaneous coronary interventions (in ACS or elective surgery). The possibility of prescription ..."
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... with severe HCh was 18.3%. Monotherapy with atorvastatin (34.2%) or rosuvastatin (31.8%), combined therapy ..."
 
1 - 100 of 501 Items 1 2 3 4 5 6 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)